Business · 18/04/2016Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Prescription Requirements for Compounding Human Drug Products
Summary
The FDA has announced the availability of a draft guidance outlining its policy on prescription requirements for compounding human drug products for individual patients under the FD&C Act, covering anticipatory compounding and office use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →